Metabolite may predict cancer versus autism risk in PTEN patients

[News]

In a new study published in American Journal of Human Genetics, a team of researchers led by Charis Eng, M.D., Ph.D., Chair of Cleveland Clinic's Genomic Medicine Institute, identified a metabolite that may predict whether individuals with PTEN mutations will develop cancer or autism spectrum disorder.

More... (https://www.news-medical.net/news/20190926/Metabolite-may-predict-cancer-versus-autism-risk-in-PTEN-patients.aspx)